Stout Jay S

Chief Technology OfficerImmunovant, Inc. (IMVT) · full profile →Form 4 · filed Jan 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$32K
Net Open-Market Flow
-$32K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2026Sell(S)1K$26.51$30K200K
Jan 7, 2026Sell(S)55$26.92$1K200K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001764013-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly: